qz
Bayer is acquiring eye disease drug developer Perfuse Therapeutics for up to $2.45 billion

Bayer will pay $300 million upfront, with the remainder tied to development, regulatory, and commercial milestones [...]

Rating

Innovation

Pricing

Technology

Usability

We have discovered similar tools to what you are looking for. Check out our suggestions for similar AI tools.

thenextweb
UCB pays up to $2.2bn for Candid Therapeutics, doubling down on T-cell engagers in autoimmune disease

The Belgian pharma is buying a two-year-old San Diego biotech for $2bn upfront, the second TCE bet it has placed in months. The thesis: B-cell killers built for cancer can rewire how autoimmune diseas [...]

Match Score: 43.84

qz
BioMarin is acquiring Alesta Therapeutics for $275 million to develop a first oral rare bone disease treatment

The deal gives BioMarin access to ALE1, a small-molecule drug in early-stage trials that could become the first oral therapy for hypophosphatasia [...]

Match Score: 42.63

thenextweb
Cambridge biotech STORM Therapeutics raises $56M

STC-15 is the world’s first RNA-modifying enzyme inhibitor to reach human trials. Phase 1 showed durable tumour regression across multiple sarcoma subtypes. The $56M Series C is backed entirely by e [...]

Match Score: 40.15

Destination
The FDA clears the first blood test for diagnosing Alzheimer's disease

There's a new way to screen for early detection of Alzheimer's disease. On Friday, the Food and Drug Administration (FDA) cleared the first blood test for the disorder. Fujirebio Diagnostics [...]

Match Score: 39.00

Destination
Peter Thiel is utterly wrong about Alzheimer's

The New York Times ran a lengthy interview this morning between columnist Ross Douthat and venture capitalist and PayPal founder Peter Thiel. There's a reason it was published in the opinion sect [...]

Match Score: 39.00

Destination
Viking Therapeutics closer to bringing its Ozempic competitor to market

Viking Therapeutics (VKTX), the developer of a promising experimental weight-loss drug, has announced a multi-year partnership with CordenPharma, a leading contract manufacturing firm.Read more... [...]

Match Score: 37.66

venturebeat
Microsoft's AI Futurist explains how he uses Copilot — and the real-world problems enterprises are solving with agents

Microsoft used its Build 2026 conference this week to push a clear message: agents are rapidly moving into production throughout enterprise systems, and the winning platform will be the one that gives [...]

Match Score: 33.54

venturebeat
Stanford researchers will discuss their agentic 'scientists' that are on course to reshape drug discovery at VB Transform 2026

Drug discovery is notoriously inefficient. Pharmaceutical projects span years, moving from one specialized human team to the next through disconnected workflows that result in knowledge loss during ea [...]

Match Score: 33.43

Destination
Stripe is reportedly acquiring AI startup OpenRouter for more than $7 billion

According to Bloomberg, Stripe is acquiring the AI startup OpenRouter for more than $7 billion, up from a latest valuation of $1.3 billion. OpenRouter offers access to over 400 AI models, has eight mi [...]

Match Score: 33.22